127 related articles for article (PubMed ID: 34081633)
21. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.
Nagao T; Gaffey TA; Serizawa H; Iwaya K; Watanabe A; Yoshida T; Yamazaki K; Sageshima M; Lewis JE
Am J Clin Pathol; 2004 Aug; 122(2):222-31. PubMed ID: 15323139
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
Hsieh MS; Lee YH; Jin YT; Kuo YJ
Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
[TBL] [Abstract][Full Text] [Related]
23. Novel therapeutic targets in salivary duct carcinoma uncovered by comprehensive molecular profiling.
Gargano SM; Senarathne W; Feldman R; Florento E; Stafford P; Swensen J; Vranic S; Gatalica Z
Cancer Med; 2019 Dec; 8(17):7322-7329. PubMed ID: 31609094
[TBL] [Abstract][Full Text] [Related]
24. Salivary duct carcinoma: A report of 70 FNA cases and review of the literature.
Wakely PE
Cancer Cytopathol; 2022 Aug; 130(8):595-608. PubMed ID: 35255198
[TBL] [Abstract][Full Text] [Related]
25. Salivary Duct Carcinoma: An Update on Morphologic Mimics and Diagnostic Use of Androgen Receptor Immunohistochemistry.
Udager AM; Chiosea SI
Head Neck Pathol; 2017 Sep; 11(3):288-294. PubMed ID: 28321773
[TBL] [Abstract][Full Text] [Related]
26. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
Fan CY; Wang J; Barnes EL
Am J Surg Pathol; 2000 Apr; 24(4):579-86. PubMed ID: 10757407
[TBL] [Abstract][Full Text] [Related]
27. [Salivary duct carcinoma].
Hungermann D; Roeser K; Buerger H; Jäkel T; Löning T; Herbst H
Pathologe; 2005 Sep; 26(5):353-8. PubMed ID: 16041504
[TBL] [Abstract][Full Text] [Related]
28. Oncocytic features in salivary duct carcinoma, a potential pitfall for misdiagnosis as Warthin tumor in fine needle aspiration specimens: A cytomorphologic analysis of 14 cases.
Goswami A; Zhang AJ; Vahidi S; Mettler T; Stewart J; Amin K
Diagn Cytopathol; 2020 Jul; 48(7):604-609. PubMed ID: 32271502
[TBL] [Abstract][Full Text] [Related]
29. Reciprocal and Autonomous Glucocorticoid and Androgen Receptor Activation in Salivary Duct Carcinoma.
Mitani Y; Lin SH; Pytynia KB; Ferrarotto R; El-Naggar AK
Clin Cancer Res; 2020 Mar; 26(5):1175-1184. PubMed ID: 31772120
[TBL] [Abstract][Full Text] [Related]
30. PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study.
Ozcan A; Shen SS; Hamilton C; Anjana K; Coffey D; Krishnan B; Truong LD
Mod Pathol; 2011 Jun; 24(6):751-64. PubMed ID: 21317881
[TBL] [Abstract][Full Text] [Related]
31. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
Jaehne M; Roeser K; Jaekel T; Schepers JD; Albert N; Löning T
Cancer; 2005 Jun; 103(12):2526-33. PubMed ID: 15900577
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors.
Nikitakis NG; Tosios KI; Papanikolaou VS; Rivera H; Papanicolaou SI; Ioffe OB
Mod Pathol; 2004 Apr; 17(4):407-15. PubMed ID: 14976534
[TBL] [Abstract][Full Text] [Related]
33. Sarcomatoid salivary duct carcinoma.
Padberg BC; Sasse B; Huber A; Pfaltz M
Ann Diagn Pathol; 2005 Apr; 9(2):86-92. PubMed ID: 15806515
[TBL] [Abstract][Full Text] [Related]
34. Osteoclast-type giant cell tumor of minor salivary gland with mucin-rich salivary duct carcinoma: a case report of unusual histology with immunohistochemical analysis.
Kusafuka K; Nakamura S; Asano R; Kamijo T; Iida Y; Onistuka T; Nakajima T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun; 109(6):870-7. PubMed ID: 20346712
[TBL] [Abstract][Full Text] [Related]
35. Alterations associated with androgen receptor gene activation in salivary duct carcinoma of both sexes: potential therapeutic ramifications.
Mitani Y; Rao PH; Maity SN; Lee YC; Ferrarotto R; Post JC; Licitra L; Lippman SM; Kies MS; Weber RS; Caulin C; Lin SH; El-Naggar AK
Clin Cancer Res; 2014 Dec; 20(24):6570-81. PubMed ID: 25316813
[TBL] [Abstract][Full Text] [Related]
36. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
[TBL] [Abstract][Full Text] [Related]
37. Gastric Metastasis from Salivary Duct Carcinoma Mimicking Scirrhous Gastric Cancer.
Kishimoto K; Shibagaki K; Araki A; Murakami K; Takahashi Y; Kotani S; Oka A; Yazaki T; Fukuba N; Mishima Y; Oshima N; Kawashima K; Ishimura N; Kadota K; Ishihara S
Intern Med; 2024 Feb; 63(3):373-378. PubMed ID: 37344429
[TBL] [Abstract][Full Text] [Related]
38. Salivary duct carcinoma.
Hosal AS; Fan C; Barnes L; Myers EN
Otolaryngol Head Neck Surg; 2003 Dec; 129(6):720-5. PubMed ID: 14663441
[TBL] [Abstract][Full Text] [Related]
39. Salivary duct carcinoma--a highly aggressive salivary gland tumor with HER-2/neu oncoprotein overexpression.
Skálová A; Stárek ; Kucerová V; Szépe P; Plank L
Pathol Res Pract; 2001; 197(9):621-6. PubMed ID: 11569926
[TBL] [Abstract][Full Text] [Related]
40. Salivary Duct Carcinoma: An Aggressive Salivary Gland Carcinoma with Morphologic Variants, Newly Identified Molecular Characteristics, and Emerging Treatment Modalities.
Rahman M; Griffith CC
Surg Pathol Clin; 2021 Mar; 14(1):111-126. PubMed ID: 33526216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
